# Dobutamaine Versus Milrinone in Cardiorenal Syndrome

> **NCT02644057** · PHASE2 · WITHDRAWN · sponsor: **Maimonides Medical Center**

## Conditions studied

- Cardiorenal Syndrome

## Interventions

- **DRUG:** Milrinone
- **DRUG:** Dobutamine

## Key facts

- **NCT ID:** NCT02644057
- **Lead sponsor:** Maimonides Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Could not enroll patients
- **Last updated:** 2018-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02644057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02644057, "Dobutamaine Versus Milrinone in Cardiorenal Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02644057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*